Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
17.2M
-
Number of holders
-
66
-
Total 13F shares, excl. options
-
8.56M
-
Shares change
-
+2.21M
-
Total reported value, excl. options
-
$61M
-
Value change
-
+$15.8M
-
Number of buys
-
36
-
Number of sells
-
-21
-
Price
-
$7.12
Significant Holders of Journey Medical Corp - Common Stock (DERM) as of Q3 2025
71 filings reported holding DERM - Journey Medical Corp - Common Stock as of Q3 2025.
Journey Medical Corp - Common Stock (DERM) has 66 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.56M shares
of 17.2M outstanding shares and own 49.78% of the company stock.
Largest 10 shareholders include TANG CAPITAL MANAGEMENT LLC (1.85M shares), WASATCH ADVISORS LP (1.31M shares), Opaleye Management Inc. (971K shares), BlackRock, Inc. (633K shares), VANGUARD GROUP INC (615K shares), Summit Financial, LLC (380K shares), ESSEX INVESTMENT MANAGEMENT CO LLC (354K shares), GEODE CAPITAL MANAGEMENT, LLC (278K shares), RENAISSANCE TECHNOLOGIES LLC (248K shares), and Pale Fire Capital SE (229K shares).
This table shows the top 66 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.